The use of succinylcholine after sugammadex reversal.
Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University, 2-1-1-1 Midorigaoka-higashi, Asahikawa, Hokkaido, 078-8510, Japan.
Chie
C
Asakura
Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University, 2-1-1-1 Midorigaoka-higashi, Asahikawa, Hokkaido, 078-8510, Japan. iwasakih@asahikawa-med.ac.jp.
Hajime
H
Iwasaki
D000732:Androstanols; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine; D000077122:Sugammadex; D047408:gamma-Cyclodextrins
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D013390:Succinylcholine
Succinylcholine; Sugammadex